An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD
Status:
Terminated
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the benefits of treating subjects with neovascular
age-related macular degeneration (AMD) at an earlier stage of choroidal neovascularization
(CNV) as compared to those with established CNV. Additionally, the study would like to
determine the efficacy of Macugen in preserving visual function in those subjects having CNV
secondary to neovascular AMD.